[1]
Faiza Ahmed et al. 2025. Assessment of Efficacy and Safety of Tislelizumab for Esophageal Squamous Cell Carcinoma. Journal of Medical Health Research and Psychiatry. 2, 2 (Oct. 2025), 1–9. DOI:https://doi.org/10.70844/jmhrp.2025.2.2.43.